Ernst Felder

Title: The Innovative Contributions of Ernst Felder in Serinol Derivatives

Introduction

Ernst Felder is a notable inventor based in Milan, Switzerland, recognized for his contributions to the field of chemistry, particularly regarding the preparation of serinol and its derivatives. With a keen focus on developing efficient methods for synthesis, his work plays a significant role in advancing pharmaceutical and chemical research.

Latest Patents

Felder holds a patent for a groundbreaking process that simplifies the production of serinol and serinol derivatives. The patent details a method for synthesizing these compounds through the reaction of a lower 1,3-dialkoxy-isopropyl halide with ammonia or an amine. This results in the formation of a 1,3-dialkoxy-isopropylamine, followed by the removal of ether groups through heating with a hydrogen halide acid. This innovative method allows the use of inexpensive starting materials to yield high-purity products devoid of interfering isomers. The novel compounds produced are highlighted for their potential applications as pharmaceutical intermediates, X-ray contrasting agents, and even as cytostatic or psychopharmacological drugs.

Career Highlights

Ernst Felder's professional journey includes a significant position at Eprova AG, a company recognized for its expertise in chemical synthesis and development. His work in this dynamic environment has allowed him to focus on enhancing methodologies in chemical production, ultimately contributing to the company's innovative offerings in the pharmaceutical sector.

Collaborations

Felder collaborates closely with notable colleagues, including Sergio Bianchi and Heinrich Bollinger. These partnerships foster a creative atmosphere for research and development, leading to remarkable advancements in the chemistry field and enhancing the innovative capabilities of Eprova AG.

Conclusion

In conclusion, Ernst Felder's inventive spirit and collaborative efforts pave the way for significant advancements in the synthesis of serinol and its derivatives. His patented method not only contributes to the scientific community but also addresses practical applications in medicine and pharmaceutical research. As he continues his work with Eprova AG and his colleagues, the impact of his innovations is sure to resonate in the industry for years to come.